free PDF file: The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure

Functional Genomics of the Pressure Overloaded Cardiomyocyte. Is Heart Failure a Target for Etomoxir? 

Acute Heart Failure – Basic Pathomechanism and New Drug Targets.

Deficiency of EPA and DHA in heart failure - a rational teatment target:
Rupp H, Rupp TP, Alter P, Maisch B. Can J Physiol Pharmacol. 2012;90:55-73 Open Access
Mechanisms involved in the differential reduction of omega-3 and omega-6 highly unsaturated fatty acids by structural heart disease resulting in "HUFA deficiency".

Carditis Net
Cleverfood.com

Cardiorepair
Homepage